People · Operator
Named in public records as an officer, director or promoter · active 2009–2016 · Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Capital Confirmation, Inc. | — | Other Technology | Series C | $60.0M | $1.9B | 2016 |
| Shareable Ink Corp | — | Other Technology | Series A | $28.0M | $84.9M | 2012 |
| Specialized Pharmaceuticals Inc | — | Pharmaceuticals | Pre-Seed | $1.6M | $7.5M | 2009 |
| QoL meds, LLC | — | Pharmaceuticals | Seed | $1.1M | $41.8M | 2009 |
Charles Schellhorn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Schellhorn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James F. Smith | 2 | 5 |
| MICHAEL K MCMAHAN | 2 | 3 |
| Daniel Sassano | 2 | 3 |
| Michael Huffer | 2 | 2 |
| Francois Bitz | 2 | 2 |
| DAVID K ROBB | 2 | 2 |
| Glen Tullman | 1 | 12 |
| Crom Carmichael | 1 | 9 |
| Jodi Hubler | 1 | 8 |
| NICHOLAS CAYER | 1 | 4 |
| Brian Fox | 1 | 4 |
| Townes Duncan | 1 | 4 |
| Chase Perry | 1 | 4 |
| Tony Miller | 1 | 3 |
| Matthew Vettel | 1 | 3 |
| Hal Andrews | 1 | 3 |
| Richard F. Rizzo | 1 | 2 |
| Perry Chase | 1 | 2 |
| Larry Bowman | 1 | 2 |
| RICHARD RIZZO | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.